[Acquired von Willebranol syndrome--its pathophysiology, diagnosis and treatment].
Mohri
H
H
D001323:Autoantibodies; D002318:Cardiovascular Diseases / Q000150:complications; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004338:Drug Combinations; D005169:Factor VIII / Q000627:therapeutic use; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications; D009196:Myeloproliferative Disorders / Q000150:complications; D010980:Platelet Membrane Glycoproteins / Q000276:immunology; D011956:Receptors, Cell Surface / Q000276:immunology; D014842:von Willebrand Diseases / Q000209:etiology / Q000503:physiopathology; D014841:von Willebrand Factor / Q000627:therapeutic use
D001323:Autoantibodies; D004338:Drug Combinations; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D014841:von Willebrand Factor; C028254:von Willebrand factor receptor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin